We are live on ! Find out more
AI

Axiom Investors Portfolio holdings

AUM $8.99B
1-Year Est. Return 44.68%
This Fund
S&P 500
This Quarter Est. Return
+2.66%
1 Year Est. Return
+44.68%
3 Year Est. Return
+214.21%
5 Year Est. Return
+302.8%
10 Year Est. Return
+1,834.44%
AUM
$3.22B
AUM Growth
+$121M
Cap. Flow
+$81.9M
Cap. Flow %
2.54%
Top 10 Hldgs %
38.22%
Holding
150
New
21
Increased
61
Reduced
47
Closed
20

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$53.4M
2
ITUB icon
Itaú Unibanco
ITUB
+$45.2M
3
ADBE icon
Adobe
ADBE
+$42.3M
4
CMCSA icon
Comcast
CMCSA
+$42M
5
BIDU icon
Baidu
BIDU
+$38.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.96%
2 Communication Services 17.8%
3 Technology 16.92%
4 Financials 13.78%
5 Healthcare 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QSR icon
51
Restaurant Brands International
QSR
$25.8B
$11.9M 0.37%
307,450
-683,010
-69% -$23.8M
SPB icon
52
Spectrum Brands
SPB
$2.07B
$10.2M 0.32%
93,162
+22,375
+32% +$2.21M
CHKP icon
53
Check Point Software Technologies
CHKP
$13.1B
$7.9M 0.25%
90,275
-838,982
-90% -$67.5M
EEFT icon
54
Euronet Worldwide
EEFT
$2.7B
$7.28M 0.23%
98,171
-2,412
-2% -$170K
LFUS icon
55
Littelfuse
LFUS
$11.6B
$6.94M 0.22%
56,382
+21,518
+62% +$2.37M
RDY icon
56
Dr. Reddy's Laboratories
RDY
$10.2B
$6.35M 0.2%
702,500
-3,500
-0.5% -$31.3K
HELE icon
57
Helen of Troy
HELE
$693M
$6.12M 0.19%
59,065
+19,427
+49% +$1.81M
CBM
58
DELISTED
Cambrex Corporation
CBM
$6.04M 0.19%
137,395
+44,151
+47% +$1.74M
AMN icon
59
AMN Healthcare
AMN
$1.4B
$5.97M 0.19%
177,635
+62,947
+55% +$1.8M
TYL icon
60
Tyler Technologies
TYL
$12.8B
$5.76M 0.18%
44,766
+2,822
+7% +$392K
STE icon
61
Steris
STE
$23.1B
$5.7M 0.18%
+80,280
New +$5.43M
BFAM icon
62
Bright Horizons
BFAM
$3.86B
$5.63M 0.18%
86,982
-29,040
-25% -$1.87M
INDA icon
63
iShares MSCI India ETF
INDA
$6.63B
$5.53M 0.17%
211,500
-43,600
-17% -$1.11M
CSGS
64
DELISTED
CSG Systems International
CSGS
$5.26M 0.16%
+116,574
New +$4.39M
BAH icon
65
Booz Allen Hamilton
BAH
$9.15B
$4.94M 0.15%
163,275
+39,281
+32% +$1.12M
LGND icon
66
Ligand Pharmaceuticals
LGND
$6.36B
$4.75M 0.15%
71,122
+27,995
+65% +$1.7M
WDFC icon
67
WD-40
WDFC
$3.15B
$4.64M 0.14%
+43,003
New +$4.44M
UCB
68
United Community Banks
UCB
$4.28B
$4.63M 0.14%
250,743
+10,545
+4% +$187K
EGHT icon
69
8x8 Inc
EGHT
$332M
$4.58M 0.14%
455,245
+205,580
+82% +$2.25M
CAMP
70
DELISTED
CalAmp Corp.
CAMP
$4.38M 0.14%
10,630
+5,477
+106% +$2.24M
EXPO icon
71
Exponent
EXPO
$3.24B
$4.14M 0.13%
162,232
+75,702
+87% +$1.83M
EGBN icon
72
Eagle Bancorp
EGBN
$845M
$4.09M 0.13%
85,115
+20,433
+32% +$961K
STMP
73
DELISTED
Stamps.com, Inc.
STMP
$4.02M 0.12%
37,809
+3,412
+10% +$349K
HCKT icon
74
Hackett Group
HCKT
$287M
$3.98M 0.12%
263,185
+89,160
+51% +$1.27M
DLX icon
75
Deluxe
DLX
$1.15B
$3.9M 0.12%
62,461
+17,216
+38% +$959K

Similar funds

Axiom Investors's Q1 2016 Portfolio in Review

As of Q1 2016, Axiom Investors held 150 positions worth $3.22B, up 3.9% from $3.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Axiom Investors's Q1 2016 filing shows 21 new, 61 increased, 47 reduced and 20 closed positions. Its largest new stake was CVS Health: 549,054 shares worth $57M. The largest sale was Check Point Software Technologies, an estimated $67.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, down from 23% a quarter earlier, followed by Communication Services and Technology.

  • Axiom Investors's largest Q1 2016 buy was CVS Health: 549,054 shares worth $57M.
  • Axiom Investors added most to Itaú Unibanco in Q1 2016, an estimated $45.2M increase.
  • Axiom Investors's biggest Q1 2016 reduction was Check Point Software Technologies, cutting an estimated $67.5M.
  • Axiom Investors fully exited Regeneron Pharmaceuticals in Q1 2016, selling an estimated $42.2M.
  • Axiom Investors's ten largest holdings make up 38% of its $3.22B portfolio in Q1 2016.
  • Axiom Investors opened 21 new positions and closed 20 in Q1 2016.
  • Axiom Investors's portfolio value rose 3.9% quarter-over-quarter to $3.22B.

Based on Axiom Investors's 13F filing for Q1 2016, filed 12 May 2016.